248 related articles for article (PubMed ID: 30317416)
41. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
[TBL] [Abstract][Full Text] [Related]
42. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
43. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
[TBL] [Abstract][Full Text] [Related]
44. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
45. Long-term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study.
Sharma K; Premchand RK; Mittal S; Monteiro R; Libbus I; DiCarlo LA; Ardell JL; Amurthur B; KenKnight BH; Anand IS
Int J Cardiol; 2021 Jan; 323():175-178. PubMed ID: 33038408
[TBL] [Abstract][Full Text] [Related]
46. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Fukuta H; Goto T; Wakami K; Ohte N
Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
[TBL] [Abstract][Full Text] [Related]
47. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
[TBL] [Abstract][Full Text] [Related]
48. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
[TBL] [Abstract][Full Text] [Related]
50. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.
DiCarlo LA; Libbus I; Kumar HU; Mittal S; Premchand RK; Amurthur B; KenKnight BH; Ardell JL; Anand IS
ESC Heart Fail; 2018 Feb; 5(1):95-100. PubMed ID: 29283224
[TBL] [Abstract][Full Text] [Related]
51. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
52. The clinical application value of the plasma copeptin level in the assessment of heart failure with reduced left ventricular ejection fraction: A cross-sectional study.
Xu L; Liu X; Wu S; Gai L
Medicine (Baltimore); 2018 Sep; 97(39):e12610. PubMed ID: 30278578
[TBL] [Abstract][Full Text] [Related]
53. Meta-analysis Analyzing the Effect of Therapies on 6-Minute Walk Distance in Heart Failure With Reduced Ejection Fraction.
Akhtar KH; Johnston S; Zhao YD; Amil F; Ford L; Lindenfeld J; Dasari TW
Am J Cardiol; 2022 Sep; 178():72-79. PubMed ID: 35773043
[TBL] [Abstract][Full Text] [Related]
54. Yiqi Fumai Injection as an Adjuvant Therapy in Treating Chronic Heart Failure: A Meta-Analysis of 33 Randomized Controlled Trials.
Nie H; Li S; Liu M; Zhu W; Zhou X; Yan D
Evid Based Complement Alternat Med; 2020; 2020():1876080. PubMed ID: 32922505
[TBL] [Abstract][Full Text] [Related]
55. Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.
Sant'Anna LB; Couceiro SLM; Ferreira EA; Sant'Anna MB; Cardoso PR; Mesquita ET; Sant'Anna GM; Sant'Anna FM
Front Cardiovasc Med; 2021; 8():766676. PubMed ID: 34901227
[No Abstract] [Full Text] [Related]
56. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
Shi L; Huang L; Yin E; Deng J; Du X
PLoS One; 2023; 18(12):e0295344. PubMed ID: 38048301
[TBL] [Abstract][Full Text] [Related]
57. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
58. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
59. Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
Li M; Ma W; Fan F; Yi T; Qiu L; Wang Z; Weng H; Zhang Y; Li J; Huo Y
J Cardiol; 2023 Jun; 81(6):513-521. PubMed ID: 36758670
[TBL] [Abstract][Full Text] [Related]
60. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
